Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

OptraSCAN Appoints Dr. Clive Taylor as Chief Medical Officer

OptraSCAN,Inc.
Posted on: 08 Nov 16

OptraSCAN, Inc. today announced that Dr. Clive Taylor has been appointed as OptraSCAN’s consulting Chief Medical Officer. Dr. Taylor has been a part of OptraSCAN’s Advisory Board helping to lead OptraSCAN into new markets and initiatives, including Cancer Moonshot 2020.

Dr. Clive Taylor is also Professor of Pathology at the University of Southern California and Editor-in-Chief of Applied Immunohistochemistry and Molecular Morphology. Professor Taylor’s primary research relates to advanced methods of diagnosis and treatment of cancer, by immunologic and molecular methods, with emphasis upon standardization and quantification. He has published more than 400 papers plus 20 books. Professor Clive Taylor attended medical school at the University of Cambridge and completed his doctoral studies in Immunology at Oxford. “I see digital pathology as the next logical step in microscopy. OptraSCAN is, in essence, an intelligent microscope, that will place a whole new range of objective analytical tools in the hands of the surgical pathologist, with radical improvements in what we do, and how we do it,” said Dr. Taylor.

“We are pleased to introduce Dr. Taylor as our Chief Medical Officer. His advisory insights and expertise over the last couple years have helped OptraSCAN continue our mission to make Digital Pathology accessible to all,” said Abhi Gholap, OptraSCAN Founder and CEO. “OptraSCAN is working to expand its product line and there are several new endeavors that Dr. Taylor will strategically help us oversee as the Company continues to grow and reach new markets. OptraSCAN’s inclusion into Cancer Moonshot eco-system is one such mission that Dr. Taylor will lead in the near future.”

About OptraSCAN, Inc.

OptraSCAN (www.optrascan.com) for research-use-only, is the first On-Demand Digital Pathology System to provide a comprehensive, affordable end-to-end Digital Pathology solution for both low and high throughput users. OptraSCAN serves as a perfect tool for the transition from conventional microscopy to Digital Pathology for the effective acquisition of Whole Slide images, viewing, sharing, analysis and management of digital slides and associated metadata. The On-Demand solutions include a small-footprint, high and low throughput WSI scanner OptraSCANTM, an integrated image viewer and image management system ImagePathTM and telepathology TELEPathTM, image analysis OptraASSAYSTM and CARDSTM (computer aided region detection system), as well as 10 TB of complimentary cloud storage. Focused on delivering fully integrated Digital Pathology solutions that maximize quality, efficiency and throughput of its customer’s pathology lab (at minimized cost), paired with a complimentary Whole Slide image scanner and viewer—OptraSCAN provides a complete Whole Slide Image solution system via an On-Demand pay-per-use program. Follow OptraSCAN on Linkedin and Twitter.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161108005150/en/

Business Wire
www.businesswire.com

Last updated on: 08/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.